Tržní kapitalizace společnosti Telesis Bio Inc
Jaká je hodnota metriky Tržní kapitalizace společnosti Telesis Bio Inc?
Hodnota metriky Tržní kapitalizace společnosti Telesis Bio Inc je $2.81B
Jaká je definice metriky Tržní kapitalizace?
Tržní kapitalizace (Market cap) je tržní hodnotou vydaných akcií obchodované společnosti a rovná se ceně akcií v daném čase vynásobené počtem kusů vydaných akcií .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Tržní kapitalizace společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Telesis Bio Inc
Čemu se věnuje společnost Telesis Bio Inc?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Firmy s metrikou tržní kapitalizace podobnou společnosti Telesis Bio Inc
- Hodnota metriky Tržní kapitalizace společnosti Beijing Digital Telecom Co je $2.81B
- Hodnota metriky Tržní kapitalizace společnosti Axcelis Technologies Inc je $2.81B
- Hodnota metriky Tržní kapitalizace společnosti Bancfirst je $2.81B
- Hodnota metriky Tržní kapitalizace společnosti Telephone And Data Systems je $2.81B
- Hodnota metriky Tržní kapitalizace společnosti Qifu Technology je $2.81B
- Hodnota metriky Tržní kapitalizace společnosti AbCellera Biologics je $2.81B
- Hodnota metriky Tržní kapitalizace společnosti Telesis Bio Inc je $2.81B
- Hodnota metriky Tržní kapitalizace společnosti H&K Ag je $2.81B
- Hodnota metriky Tržní kapitalizace společnosti First Capital Real Estate Investment Trust je $2.81B
- Hodnota metriky Tržní kapitalizace společnosti Nordstrom je $2.81B
- Hodnota metriky Tržní kapitalizace společnosti Boise Cascade Co je $2.82B
- Hodnota metriky Tržní kapitalizace společnosti Rush Enterprises Inc je $2.82B
- Hodnota metriky Tržní kapitalizace společnosti Bausch Health Companies Inc je $2.82B